Does Higher Dose Of Wegovy Result In More Weight Loss? Novo Nordisk Seeks European Approval

benzinga.com/news/health-care/25/07/46300943/does-higher-dose-of-wegovy-result-in-more-weight-loss

Novo Nordisk A/S (NYSE:NVO) on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).
The submission is based on clinical data from the STEP UP…

This story appeared on benzinga.com, 2025-07-08 15:58:34.
The Entire Business World on a Single Page. Free to Use →